The MAPK/ERK signaling pathway is another crucial target for inhibitors. This pathway is associated with managing cell distinction, survival, and growth. Inhibitors targeting MAPK/ERK are employed in cancer cells treatments to avoid uncontrolled cell proliferation and lump development. JAK/STAT signaling inhibitors modulate immune feedbacks and are